Surprise Finding Points to Next-Gen Sequencing's Utility for Vaccine Quality Control
April 06, 2010
Surprise Finding Points to Next-Gen Sequencing's Utility for Vaccine Quality Control
The unexpected discovery of a nonpathogenic pig virus in a rotavirus vaccine indicates that next-generation sequencing may be an effective quality-control tool in vaccine development.
Full-text access for premium subscribers only.
Existing premium subscribers login here.
New to GenomeWeb? Register here quickly.
New to GenomeWeb? Register here quickly.
Related Stories
- HudsonAlpha Researchers to Sequence Immune Repertoires of 10K Individuals for 100 Diseases
May 24, 2011 / Clinical Sequencing News - Merck, GSK, J&J Embrace Targeted Sequencing for Drug Development and Biomarker Studies
August 10, 2010 / In Sequence - FDA Seeks Sequencing Services for Evaluation of Viral Vaccine QC Technology
June 1, 2010 / In Sequence - FDA Considers Sequencing for Quality-Control Testing of Vaccines
May 11, 2010 / In Sequence - Consortium Sequences Gut Microbiomes for 124 People on Illumina GA
March 9, 2010 / In Sequence